Industry reports
Editor highlights

Pharmaceutical Analysis & Statistics in Europe Countries, April 2014

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

1-30 of 35 reports
Advanced in the Rheumatoid Arthritis Market

Advanced in the Rheumatoid Arthritis Market

  • $ 1 741
  • Industry report
  • January 2014
  • by Espicom Business Intelligence

Rheumatoid arthritis (RA) is a chronic disorder for which there is currently no cure It affects around 23 5 million adults in the world (WHO, 2013) and approximately 294,000 children under the age of ...

  • Industries : Pathology
  • Countries : Japan, United States, Russian Federation, Europe, India, China
Orphan Drugs: Market Environment Products and Companies

Orphan Drugs: Market Environment Products and Companies

  • $ 1 566
  • Industry report
  • December 2012
  • by Espicom Business Intelligence

The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry's interest in orphan drugs; and provide hope to ...

  • Industries : Drug and Medication
  • Countries : United States, Australia, Japan, Sweden
The Pharmaceutical Market: Finland

The Pharmaceutical Market: Finland

  • $ 1 313
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : Finland
The Pharmaceutical Market: Denmark

The Pharmaceutical Market: Denmark

  • $ 1 313
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : Denmark
The Pharmaceutical Market: Austria

The Pharmaceutical Market: Austria

  • $ 1 313
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens ...

  • Industries : Pharmaceutical
  • Countries : Austria
The Pharmaceutical Market: Norway

The Pharmaceutical Market: Norway

  • $ 1 313
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : Norway
The Pharmaceutical Market: Belgium

The Pharmaceutical Market: Belgium

  • $ 1 313
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens ...

  • Industries : Pharmaceutical
  • Countries : Belgium
The Pharmaceutical Market: UK

The Pharmaceutical Market: UK

  • $ 1 313
  • Industry report
  • June 2012
  • by Espicom Business Intelligence

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

  • Industries : Pharmaceutical
  • Countries : United Kingdom
Gedeon Richter Generics Company Intelligence Report

Gedeon Richter Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Hungary
ratiopharm Generics Company Intelligence Report

ratiopharm Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Germany, Canada, Europe, Netherlands, World, North America, United Kingdom
Stada Arzneimittel Generics Company Intelligence Report

Stada Arzneimittel Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Germany
Krka Generics Company Intelligence Report

Krka Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Europe, Slovenia, Germany, World, China
Ranbaxy Generics Company Intelligence Report

Ranbaxy Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : South Africa, Canada, India, World, Africa, United States, Romania, Japan, Mexico, Malaysia, China, North America, Asia, Europe
Sanofi-Aventis Generics Company Intelligence Report

Sanofi-Aventis Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Czech Republic, United Kingdom, Europe, Brazil, France, Germany, South America, World, Mexico, Slovakia (slovak Republic), Romania, Portugal
Actavis Generics Company Intelligence Report

Actavis Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : United States, Europe, Iceland, Switzerland, Bulgaria, France, Germany, World, Netherlands, Norway, United Kingdom, Sweden, Spain, Russian Federation, Ireland, Austria, China, Serbia and Montenegro, North America
Egis Generics Company Intelligence Report

Egis Generics Company Intelligence Report

  • $ 341
  • Company report
  • January 2011
  • by Espicom Business Intelligence

Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...

  • Industries : Generic Drug
  • Countries : Hungary, Europe, Russian Federation, France, Austria, South Korea, World
Bayer: Pipeline - Products ? Performance - Potential

Bayer: Pipeline - Products ? Performance - Potential

  • $ 1 041
  • Company report
  • November 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Over-the-counter Drug
  • Countries : Germany
Multiple Sclerosis Drug Discoveries: what the future holds

Multiple Sclerosis Drug Discoveries: what the future holds

  • $ 2 266
  • Industry report
  • October 2010
  • by Espicom Business Intelligence

EXTENSIVE ANALYSIS OF THE GLOBAL MULTIPLE SCLEROSIS MARKET AND ASSESSMENT OF ALL SIGNIFICANT CURRENT AND FUTURE PRODUCTS The recent approval in the US of Novartis' orally administered Gilenya (fingolimod) ...

  • Industries : Drug Discovery and Development, Pathology
  • Countries : World, Russian Federation
Epigenetics: Current and future applications that are driving novel drug discovery

Epigenetics: Current and future applications that are driving novel drug discovery

  • $ 1 218
  • Industry report
  • August 2010
  • by Espicom Business Intelligence

Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, ...

  • Industries : Drug Discovery and Development, Genomics
  • Countries : United States, Germany, Denmark, World, Canada
Lung Cancer: Global Incidence, Prevalence and Mortality to 2015

Lung Cancer: Global Incidence, Prevalence and Mortality to 2015

  • $ 1 743
  • Industry report
  • July 2010
  • by Espicom Business Intelligence

Lung cancer is expected to account for an estimated 12.5% of all new cancer cases in the leading economies in 2010, giving it the second highest incidence, marginally behind colorectal cancer and just ...

  • Industries : Pathology, Healthcare
  • Countries : Japan, United States, France, Spain, Germany, Italy, United Kingdom, World, Europe
Gilead Sciences:  Pipeline - Products ? Performance - Potential

Gilead Sciences: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • February 2010
  • by Espicom Business Intelligence

Gilead's HIV product portfolio remains its strongest asset, generating 81.2 per cent of total company sales in 2008. Atripla and Truvada are expected have combined sales approaching US$5 billion by 2013, ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Ireland, United States
Gilead Sciences: Pipeline - Products ? Performance - Potential

Gilead Sciences: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • February 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Ireland, Japan
Alcon:  Pipeline - Products ? Performance - Potential

Alcon: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • February 2010
  • by Espicom Business Intelligence

Alcon is a research and development-driven global company which develops, manufactures and markets pharmaceuticals, surgical equipment and devices, and consumer products to treat diseases and disorders ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Switzerland
Alcon: Pipeline - Products ? Performance - Potential

Alcon: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • February 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Drug and Medication, Medical Devices, Pharmaceutical
  • Countries : Switzerland
UCB:  Pipeline - Products ? Performance - Potential

UCB: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • January 2010
  • by Espicom Business Intelligence

UCB is a global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of CNS disorders, allergy/respiratory ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Europe, South Korea, Belgium, World, Switzerland, United States, Spain, Italy, Germany, Japan, India
UCB: Pipeline - Products ? Performance - Potential

UCB: Pipeline - Products ? Performance - Potential

  • $ 1 165
  • Company report
  • January 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : Europe, South Korea, Belgium, World, Switzerland, United States, Spain, Italy, Germany, Japan, India
AstraZeneca:  Pipeline - Products ? Performance - Potential

AstraZeneca: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • October 2009
  • by Espicom Business Intelligence

On 6th April 1999, AstraZeneca was formed through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK, propelling the company to second in the world in terms of pharmaceutical sales. Since ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Sweden
Zentiva Generics Company Intelligence Report

Zentiva Generics Company Intelligence Report

  • $ 343
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Zentiva was created through the merger of the Czech company, L├ęciva, and the Slovak firm Slovakofarma, which was completed in August 2003. The two former companies began selling products under the Zentiva ...

  • Industries : Generic Drug
  • Countries : Turkey, Slovakia (slovak Republic), Czech Republic, Europe, Lithuania, Ukraine, Russian Federation, Romania, Poland, Latvia, Bulgaria, World
Bayer:  Pipeline - Products ? Performance - Potential

Bayer: Pipeline - Products ? Performance - Potential

  • $ 1 043
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Bayer is a global enterprise, headquartered in Germany, with core competencies in the fields of healthcare, nutrition and high-tech materials, and organised into three subgroups, namely HealthCare, CropScience ...

  • Industries : Over-the-counter Drug, Pharmaceutical
  • Countries : Germany
AstraZeneca: Pipeline - Products ? Performance - Potential

AstraZeneca: Pipeline - Products ? Performance - Potential

  • $ 1 165
  • Company report
  • October 2009
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Sweden, Singapore

» View Public Reports

About 4 000 reports

The British Antibiotic Sector

  • Industry report
  • April 2014
  • 37 pages

... Research to have a major impact in reducing the burden of the disease) priority medicines for europe and the world, warren kaplan and richard laing, world health organisation, department of essential drugs ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.